IgG / Novartis / Elsevier Inc. / mCi / USA 6 Max F. Perutz Laboratories / GE Healthcare / /
Country
Switzerland / /
Currency
pence / / /
Facility
University of Basel / C terminus of Sch9 / Princeton University / TOR complex / C terminus / Gustav Ammerer / 6 Howard Riezman / 2 James R. Broach / 5 Claudio De Virgilio / 3 Michael N. Hall / The Sch9 C terminus / Centre Me´dical Universitaire University of Geneva / Sch9 C terminus / Terminal Residues / N terminus / C terminal / Terminal Portion / C Terminus of Sch9 To / University of Vienna / C terminus of Vac8-cSch9-3HA / C terminus of Vac8 / /
IndustryTerm
urea-based media / machinery / fragmentation product / activation loop phosphorylation site / translation machinery / chemical reagents / media lacking / gene products / cleavage site / qPCR protocol / important site / /
University of Basel / National Institute of Health / Princeton University / Department of Molecular Biology Department of Biochemistry / Department of Microbiology / Department of Molecular Biology / University of Vienna / University of Geneva / Geneva / Swiss National Science Foundation / Department of Microbiology and Molecular Medicine / /
Person
Wolfgang Oppliger / Elisabetta Cameroni / Didier Picard / Tom Sturgill / le Rifat / Philippe Demougin / Bohrgasse / /
Molecular Cell Article Sch9 Is a Major Target of TORC1 in Saccharomyces cerevisiae Jo¨rg Urban,1 Alexandre Soulard,4 Alexandre Huber,1 Soyeon Lippman,5 Debdyuti Mukhopadhyay,2